Pay in 4 interest-free payments of $22.50 Learn more
Ships within 48 hours · Estimated delivery Oct 13 - Oct 18
a new anti-cancer drug candidate
Bephenium is an anthelmintic agent formerly used in the treatment of hookworm infections and ascariasis
KAN0438757 is a potent and selective inhibitor of the metabolic kinase PFKFB3 (6-Phosphofructo-2-Kinase/Fructose-2
at the end of the study
PubMed PMID: 21465936
TAK-063 Size:Solid 10 mg a new anti-cancer drug candidateTAK 063, also known as Balipodect., is a highly potent, selective, and orally active phosphodiesterase 10A (PDE10A) inhibitor. TAK 063 is currently being evaluated in clinical trials for the treatment of schizophrenia. Phosphodiesterase 10A (PDE10A) is a cAMP cGMP phosphodiesterase highly expressed in medium spiny neurons (MSNs) in the striatum. TAK 063 represents a promising drug for the treatment of schizophrenia with potential for superior safety